Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Febit Achieves Sales Goals

Published: Thursday, March 16, 2006
Last Updated: Monday, March 27, 2006
Bookmark and Share
Febit successfully markets the GENIOM bioanalysis device.

Febit biotech gmbh has announced that it has successfully concluded the business year, meeting its sales goals for 2005.

Sales of GENIOM™, a biochip-driven nucleic acid analysis system, were on budget already in the year of Febit's re-establishment.

This development is based on the fundamental restructuring and re-establishment of Febit biotech gmbh in spring 2005 when the company moved into new quarters in the Heidelberg Technologiepark.

Since its reorganization, Febit is supported by Dietmar and Oliver Hopp, two experienced biotech investors interested in a favourable long-term development of the company.

Integrating its structural and financial basis, Febit's re-establishment was supported by Prof. Christof Hettich, an experienced consultant from the Rittershaus firm of Mannheim.

In October 2005 the management team around Cord F. Stahler, CEO of Febit biotech gmbh was expanded, a supervisory board was established and the headcount was gradually increased.

The team consisting of management, staff and supervisory board boasts know-how and skills in all relevant areas. 

Febit has become a valuable cooperation partner in the biotech field, which is illustrated by a number of licence agreements signed in late 2005.

From Oxford Gene Technology, Febit acquired a license for the southern array technique, a method of major impact in gene research, thus enhancing its position with respect to intellectual property on the global market.

In a license agreement with the German Cancer Reseach Center (DKFZ), Febit acquired the rights to an alternative high-efficacy DNA synthesis method for use in its GENIOM® platform.       

Dr. Jorg Hoheisel at the DKFZ strongly supports the GENIOM® platform, said, "This DNA analysis device offers tremendous flexibility and has an extraordinary potential. It is invaluable for many aspects of our work at the DKFZ."   

The product website went online recently, complementing the corporate website and broadening Febit´s internet information resources for customers, investors and the public.

In February 2005, the Febit facilities were substantially enlarged and the headcount will reach 50 at the end of 2006 in order to realize the expansion plans and to ensure reliable product quality and availability. 

Cord F. Stahler, Chief Executive Officer of Febit biotech gmbh is confident to generate substantial growth within 2006, "The changes we made in 2005 and our network allow us to rapidly expand our position on the international market."

"The global market of DNA analysis devices will keep growing substantially in the next years. Febit will participate in this growth due to significant product advantages and the market-readiness of GENIOM®."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Geniom Technology Applied to Targeted Next-Generation Sequencing
By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes
Tuesday, July 24, 2007
Febit Establishes US Company
Febit launches the GENIOM biochip system in the US.
Tuesday, August 15, 2006
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!